CINECA IRIS Institutional Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
EnglishThe recent decrease in mortality related to cardiovascular diseases has largely been due to the more effective treatment of cardiovascular risk factors and secondary prevention therapies. More people than ever are now on long-term medications. Hypertension, which is one of the most common cardiovascular risk factors, requires life-long treatment. Recent evidence has focused attention on the risk of cancer that may be associated with the long-term use of antihypertensive therapy. This article summarises available evidence surrounding three recent events in this setting. Even though this is a crucial patient safety issue, there are no conclusive answers at this time and further studies are required.
Recent Warnings about Antihypertensive Drugs and Cancer Risk: Where Do They Come From? / Battistoni, Allegra; Volpe, Massimo. - In: EUROPEAN CARDIOLOGY. - ISSN 1758-3756. - 15:Apr 30(2020), pp. 1-5.
| Titolo: | Recent Warnings about Antihypertensive Drugs and Cancer Risk: Where Do They Come From? |
| Autori: | |
| Data di pubblicazione: | 2020 |
| Rivista: | |
| Citazione: | Recent Warnings about Antihypertensive Drugs and Cancer Risk: Where Do They Come From? / Battistoni, Allegra; Volpe, Massimo. - In: EUROPEAN CARDIOLOGY. - ISSN 1758-3756. - 15:Apr 30(2020), pp. 1-5. |
| Handle: | http://hdl.handle.net/11573/1424319 |
| Appartiene alla tipologia: | 01a Articolo in rivista |
File allegati a questo prodotto
| File | Note | Tipologia | Licenza | |
|---|---|---|---|---|
| Battistoni_Recent-Warnings_2020.pdf | Versione editoriale (versione pubblicata con il layout dell'editore) |  | Open Access Visualizza/Apri |
http://hdl.handle.net/11573/1424319
Copyright © 2020